Skip to main content
Filing year 2024

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

Omaha, Nebraska·EIN 84-1363353·NTEE H30 · Medical Research·501(c)(3)
Total revenue
$7.2M
Total assets
$3.8M
Total expenses
$6.3M
Reported officers
23
Mission

FACT IS A NON-PROFIT CORPORATION FOUNDED TO IMPROVE THE QUALITY OF CELLULAR THERAPY THROUGH PEER-DEVELOPED STANDARDS, EDUCATION AND ACCREDITATION FOR THE BENEFIT OF PATIENTS.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 5 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

Chief MED Officer
Officer (Unspecified)
$348k
$374k
Base
$348k
Bonus
Other
Benefits
Senior Medical Officer
Highest Compensated Employee
Median to 75th percentile
$263k
$283k
Base
$263k
Bonus
Other
Benefits
Chief Exec Officer
Officer (Unspecified)
$238k
$256k
Base
$238k
Bonus
Other
Benefits
Chief Oper Officer
Officer (Unspecified)
$238k
$256k
Base
$238k
Bonus
Other
Benefits
Director of Technology Ser
Highest Compensated Employee
10th to 25th percentile
$131k
$141k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the Midwest region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 18 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY equaled 5% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
5%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Up 4%
from 2023

From $333k in 2023 to $348k in 2024.

$333k
2023
$348k
2024
In today's dollarsEst.
Up 2% in real terms$368k to $374k

Estimated with BLS CPI-U for the Midwest region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Highest Compensated Employee pay rose 143% from 2023 to 2024, while revenue rose 31%.

$108k in 2023 to $263k in 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.
Financial trend

Revenue and expenses over time

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY reported revenue and expenses across 2 filing years.

RevenueExpenses
$5.5M
$5M
2023
$7.2M
$6.3M
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Medical Research executives earn

Comparable medical research organizations nationwide pay their highest-earning executive a median of $120,264.

25th percentile
$48k
Median
$120,264
75th percentile
$252k
90th percentile
$466k

These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).

See full Medical Research compensation data
FAQ

Common questions about FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

What does the Highest Compensated Employee of FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY earn?

In 2024, the Highest Compensated Employee of FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY received $263,000 in total compensation. This pay is above the median (the midpoint) for Highest Compensated Employee roles among Medical Research organizations nationwide, within the top half of comparable filings. Based on IRS Form 990 data.

How does Highest Compensated Employee pay at FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Highest Compensated Employee at FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY falls between the median and the 75th percentile. In 2024, the highest total compensation at FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY equaled 5% of the organization's total expenses. The median for medical research organizations is 10%.

What are FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY's revenue and expenses?

In 2024, FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY reported $7.2M in total revenue and $6.3M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.